|
HEATR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.115970E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.220020E-01 |
| Normal-vs-Stage2 |
9.437900E-03 |
| Normal-vs-Stage3 |
1.561380E-01 |
| Normal-vs-Stage4 |
9.542600E-01 |
| Stage1-vs-Stage2 |
1.317160E-01 |
| Stage1-vs-Stage3 |
9.825400E-01 |
| Stage1-vs-Stage4 |
1.615380E-01 |
| Stage2-vs-Stage3 |
1.734360E-01 |
| Stage2-vs-Stage4 |
2.358100E-02 |
| Stage3-vs-Stage4 |
2.104600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.255800E-01 |
| Normal-vs-AfricanAmerican |
8.496400E-01 |
| Normal-vs-Asian |
1.922560E-01 |
| Caucasian-vs-AfricanAmerican |
2.981800E-01 |
| Caucasian-vs-Asian |
7.875800E-01 |
| AfricanAmerican-vs-Asian |
2.326600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.696200E-02 |
| Normal-vs-Female |
1.454800E-01 |
| Male-vs-Female |
6.062600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.050800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.779600E-02 |
| Normal-vs-Age(61-80Yrs) |
4.831000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.899400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.651800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.494000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.666000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.366360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.245800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.686600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.092200E-01 |
| Classical-VS-Follicular |
2.35289999706012E-08 |
| Classical-VS-Other |
9.672100E-02 |
| Classical-VS-Normal |
7.521000E-01 |
| Tall-VS-Follicular |
2.538500E-03 |
| Tall-VS-Other |
1.525230E-01 |
| Tall-VS-Normal |
5.779600E-01 |
| Follicular-VS-Other |
8.704600E-01 |
| Follicular-VS-Normal |
2.11579999999101E-05 |
| Other-VS-Normal |
6.928400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.524000E-03 |
| Normal-vs-N1 |
2.087000E-01 |
| N0-vs-N1 |
2.378000E-01 |
|
|
